| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 4,243,700 | 6,222,600 | 5,649,600 | | Cost of Revenue | 3,235,100 | 4,119,600 | 3,359,600 | | | Gross Profit | 1,008,600 | 2,103,000 | 2,290,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 175,400 | 209,400 | 141,000 | | Non Recurring | 2,700 | 15,700 | (20,600) | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 830,500 | 1,877,900 | 2,169,600 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 373,100 | 276,400 | 101,000 | | Earnings Before Interest And Taxes | 1,203,600 | 2,154,300 | 2,270,600 | | Interest Expense | 135,100 | 84,600 | 100,400 | | Income Before Tax | 1,068,500 | 2,069,700 | 2,170,200 | | Income Tax Expense | 126,700 | 540,300 | 583,700 | | Minority Interest | (242,700) | (477,100) | (488,500) | | | | Net Income From Continuing Ops | 581,100 | 1,064,600 | 1,098,600 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| 2,000 | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 581,100 | 1,064,600 | 1,100,600 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $581,100 | $1,064,600 | $1,100,600 |
|
0.49% Nasdaq 
Income Statement
